Early Morphic data hint at a threat to Entyvio

Watch out Takeda: Morphic Therapeutic is after your inflammatory bowel disease drug Entyvio. The smaller group reported promising early data today with its lead project, MORF-057, which crucially is given orally versus Entyvio’s intravenous infusion.